Arie Roth - SMDCY Chief Medical Manager
Executive
Prof. Arie Roth, M.D., serves as Chief Medical Manager at S H L Telemedicine Ltd He has served as the Companys Chief Medical Manager since its start of operations. Prof. Roth is a Senior Member of the department of cardiology at the TelAviv Sourasky Medical Center, University of TelAviv, Israel, and received a medical degree from the Sackler School of Medicine of the University of TelAviv, Israel.
| Age | 62 |
| Phone | 972 3 561 2212 |
| Web | http://www.shl-telemedicine.com |
SMDCY Management Efficiency
The company has return on total asset (ROA) of (11.66) % which means that it has lost $11.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (42.15) %, meaning that it generated substantial loss on money invested by shareholders. SMDCY's management efficiency ratios could be used to measure how well SMDCY manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 21.3 M in total debt with debt to equity ratio (D/E) of 54.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SMDCY has a current ratio of 1.23, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist SMDCY until it has trouble settling it off, either with new capital or with free cash flow. So, SMDCY's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SMDCY sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SMDCY to invest in growth at high rates of return. When we think about SMDCY's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Arista Joyner | Boston Properties | N/A | |
| Felipe Dubernet | Compania Cervecerias Unidas | 54 | |
| Barbara Wolff | Compania Cervecerias Unidas | 48 | |
| Martin Guiraldes | Compania Cervecerias Unidas | 59 | |
| Felipe Benavides | Compania Cervecerias Unidas | ||
| Helen Han | Boston Properties | N/A | |
| Antonio Stuven | Compania Cervecerias Unidas | 36 | |
| Katie Mendolera | Haverty Furniture Companies | 41 | |
| Nicolas Lorenz | Westrock Coffee | N/A | |
| Ludovic Auvray | Compania Cervecerias Unidas | 47 | |
| Kelly Fladger | Haverty Furniture Companies | 54 | |
| Miles Fisher | Westrock Coffee | N/A | |
| Felipe Almarza | Compania Cervecerias Unidas | 44 | |
| Laura Sesody | Boston Properties | N/A | |
| Felipe Arancibia | Compania Cervecerias Unidas | 40 | |
| Matt Selinger | Westrock Coffee | N/A | |
| Juan Boned | Compania Cervecerias Unidas | 53 | |
| Marisol Leniz | Compania Cervecerias Unidas | 60 | |
| Maria Romagnoli | Compania Cervecerias Unidas | 53 | |
| Fernando Sanchis | Compania Cervecerias Unidas | 54 | |
| Ronald Lucassen | Compania Cervecerias Unidas | 54 | |
Management Performance
| Return On Equity | -42.15 | |||
| Return On Asset | -11.66 |
SMDCY Leadership Team
Elected by the shareholders, the SMDCY's board of directors comprises two types of representatives: SMDCY inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SMDCY. The board's role is to monitor SMDCY's management team and ensure that shareholders' interests are well served. SMDCY's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SMDCY's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yoni Dagan, CTO | ||
| Ehud BenYair, CFO | ||
| Dvora Kimhi, Non-Executive Director | ||
| Uzi Blumensohn, Member of the Executive Board | ||
| Nehama Ronen, Independent Non-Executive Director | ||
| Erez Nachtomy, Executive VP | ||
| Cailong Su, Non-Executive Director | ||
| Amnon Sorek, Non-Executive Director | ||
| Eli Alroy, Non-Executive Director | ||
| Martin Lehner, Managing Director of SHL Telemedizin Germany | ||
| Elon Shalev, Non-Executive Chairman of the Board | ||
| Eran Antebi, CFO | ||
| Georg Oppen, Managing Director - S H L Telemedizin | ||
| Yehoshua Abramovich, Board of Director | ||
| Nissim Zvili, Non-Executive Independent Director | ||
| Yi He, Non-Executive Director | ||
| Ziv Carthy, Non-Executive Director | ||
| Doron Steiger, Non-Executive Director | ||
| Ronen Harel, Non-Executive Independent Director | ||
| Yoav Rubinstein, Interim CEO, Head of Global Bus. Devel. and Sr. VP | ||
| Xuequan Qian, Board of Director | ||
| Erez Alroy, Co-CEO | ||
| Amir Lerman, Non-Executive Director | ||
| Shenlu Xu, Non-Executive Director | ||
| Eyal Bakshi, Non-Executive Director | ||
| Xuewen Wu, Chairman of the Board | ||
| Arie Roth, Chief Medical Manager | ||
| Yossi Vadnagra, CFO | ||
| Yoram Alroy, Founder and Pres | ||
| Yuval Shaked, CEO | ||
| Eran Kristal, General Manager - SHL Israel | ||
| Irit Alroy, CTO and Executive VP |
SMDCY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is SMDCY a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -42.15 | |||
| Return On Asset | -11.66 | |||
| Profit Margin | (55.99) % | |||
| Operating Margin | (41.19) % | |||
| Current Valuation | 85.98 M | |||
| Shares Outstanding | 10.49 M | |||
| Price To Earning | 74.59 X | |||
| Price To Book | 1.49 X | |||
| Price To Sales | 2.05 X | |||
| Revenue | 37.88 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the SMDCY information on this page should be used as a complementary analysis to other SMDCY's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in SMDCY OTC BB Equity
If you are still planning to invest in SMDCY check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SMDCY's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |